Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $250.0000 (-7.41%) ($245.0000 - $267.5000) on Tue. Feb. 21, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.48% (three month average) | RSI | 52 | Latest Price | $250.0000(-7.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(4%) PEJ(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -2.24% in a week (0% probabilities). IGOV(-2%) REMX(-1%) EWY(-1%) XLU(0%) XLP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.24% (StdDev 4.48%) | Hourly BBV | 0 () | Intraday Trend | -6.5% | | | |
|
Resistance Level | $263.82 | 5 Day Moving Average | $267(-6.37%) | 10 Day Moving Average | $265.66(-5.89%) | 20 Day Moving Average | $263.82(-5.24%) | To recent high | -16.4% | To recent low | 4.2% | Market Cap | $4.924b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |